We Support Cancer Research

Author: Charlie Schwengel, DO, DO(H)

Cancer Does Not "Strike" at Random.

The Appearance of Cancer Always Has a Reason and a Cause.

We live in natural bodies. The development, growth and appearance of the tumors that become diagnosed as "cancer" is a natural process; it is not random or malicious act of Nature. In reality, in almost all cases of cancer the real causes have very little to do with the common risk factors we all know about.

Unresolved emotional issues affect the body like stress does.

The word ‘cancer' is of Latin derivation and means "crab". Today cancer "cure" is a vast industry. But by the turn of the 20th Century organized medicine had come to the conclusion that it was not a matter of whether infectious disease caused cancer, but which one. For over two hundred years a cancer germ had been discovered and rediscovered, named and renamed, each scientist adding to the knowledge, but to no avail. Then, in 1910, certain American medical powers did a 180-degree rotation.

Pancreatic Cancer occurs more frequently in men, affecting African American and Jewish populations. People who ages 45-65 are most likely to develop pancreatic cancer. Factors that contribute in the development of pancreatic cancer are chemical carcinogens (petroleum, dry cleaning chemicals)

Cancer is a condition which most people dread. There are certain types of cancer which respond very well to modern chemotherapy and have excellent chances of recovery. Unfortunately, pancreatic cancer is not one of those cancers which is amenable to treatment. In most cases, the diagnosis of pancreatic cancer comes...

Pancreatic cancer is currently the fifth most common form of cancer in the United States and is diagnosed in around 40,000 Americans each year. In most cases pancreatic cancer has an extremely poor survival outcome. Just 1 in 20 people diagnosed with pancreatic cancer will still be alive after five...

http://www.cancer.gov/cancertopics/wyntk/pancreas/page20

Laboratory scientists are studying the pancreas to learn more about it. They are studying the possible causes of pancreatic cancer and are researching new ways to detect tumors. They also are looking for new therapies that may kill cancer cells.

The Problem

Do We Already Have Too Many Cancer Biomarker Candidates?

Although there is intense activity towards identifying novel biomarkers for cancers, especially
those for early detection, it is not clear whether we already have too many biomarkers described
in the literature. Given that there is no central repository of data pertaining to any cancer,
it is difficult to estimate if we have too many proteins described as potential biomarkers for
any cancer. Technological advances in genomics, transcriptomics, and proteomics have facilitated
high-throughput studies in which the data are analyzed in isolation and a comparison with the published
literature is not generally feasible for the entire dataset. A central repository will not only
integrate all the information scattered across the literature, but will also serve as a reference
for prioritizing and systematic testing of candidate biomarkers. Pancreatic cancer is a deadly disease
for which the available biomarkers, such as CA19-9, lack the desired sensitivity and specificity
for early detection [1]. Therefore, we took pancreatic cancer as a model and carried out a comprehensive
literature survey to systematically catalog the overexpressed genes/proteins. Our objective was to
develop a compendium of potential biomarkers that could be systematically validated by the pancreatic
cancer community and serve as a prototype for similar efforts in other cancers.